{"companyId":285625,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"ゼノン・ファーマシューティカルズ株式会社","headOfficeLocation":"カナダ、ブリティッシュコロンビア州バーナビー、ギルモアウェイ3650番地200-3650","presidentName":"イアン・モーティマー","companySummary":null,"stockCode":"XENE","currency":"USD","capital":null,"sales":null,"employees":370,"employeesConsolidated":null,"humanCheck":false,"domains":["xenon-pharma.com"],"businessContents":["臨床段階の神経科学バイオ医薬品企業","てんかんや神経障害のためのイオンチャネル標的薬の開発"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://xenon-pharma.com/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0}]}